Extracellular Vesicle-Shuttled mRNA in Mesenchymal Stem Cell Communication

Stem Cells

Volumn 35, Issue 4, 2017, Pages 1093-1105

  Ragni, Enrico ^a   Banfi, Federica ^a   Barilani, Mario ^a,b   Cherubini, Alessandro ^a   Parazzi, Valentina ^a   Larghi, Paola ^c,d   Dolo, Vincenza ^e   Bollati, Valentina ^a,d   Lazzari, Lorenza ^a  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c Istituto Nazionale di Genetica Molecolare   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

^e UNIVERSITY OF L'AQUILA   (Italy)

Author keywords

Extracellular vesicles; IL 10; Mesenchymal stem cells; mRNA

Indexed keywords

CISPLATIN; INTERLEUKIN 10; MESSENGER RNA; ORGANIC COMPOUND; PKH 26;

ANIMAL CELL; ARTICLE; BONE MARROW DERIVED MESENCHYMAL STEM CELL; CELL COMMUNICATION; CONTROLLED STUDY; CORD BLOOD MESENCHYMAL STEM CELL; CYTOSOL; EXOSOME; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; KIDNEY TUBULE CELL; KIDNEY TUBULE DAMAGE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RNA TRANSLATION; TARGET CELL; UMBILICAL CORD BLOOD; 3' UNTRANSLATED REGION; BIOLOGICAL MODEL; GENETIC TRANSCRIPTION; GENETICS; HUMAN; KINETICS; MESENCHYMAL STROMA CELL; METABOLISM; PROTEIN SYNTHESIS; REPRODUCIBILITY; RNA TRANSPORT; STAINING; ULTRASTRUCTURE;

3' UNTRANSLATED REGIONS; CELL COMMUNICATION; EXTRACELLULAR VESICLES; HUMANS; INTERLEUKIN-10; KINETICS; MESENCHYMAL STROMAL CELLS; MODELS, BIOLOGICAL; ORGANIC CHEMICALS; PROTEIN BIOSYNTHESIS; REPRODUCIBILITY OF RESULTS; RNA TRANSPORT; RNA, MESSENGER; STAINING AND LABELING; TRANSCRIPTION, GENETIC;

EID: 85012988593     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2557     Document Type: Article

References (57)

1. Ullah I, Subbarao RB, Rho GJ. Human mesenchymal stem cells - Current trends and future prospective. Biosci Rep 2015;35:e00191.
2. Crisan M, Corselli M, Chen CW et al. Multilineage stem cells in the adult: A perivascular legacy?. Organogenesis 2011;7:101–104.
3. Stoltz JF, de Isla N, Li YP et al. Stem cells and regenerative medicine: Myth or reality of the 21th century. Stem Cells Int 2015;2015:734731.
4. Gao F, Chiu SM, Motan DA et al. Mesenchymal stem cells and immunomodulation: Current status and future prospects. Cell Death Dis 2016;7:e2062.
5. Najar M, Raicevic G, Fayyad-Kazan H et al. Mesenchymal stromal cells and immunomodulation: A gathering of regulatory immune cells. Cytotherapy 2016;18:160–171.
6. Ferrand J, Noel D, Lehours P et al. Human bone marrow-derived stem cells acquire epithelial characteristics through fusion with gastrointestinal epithelial cells. PLoS One 2011;6:e19569.
7. Spees JL, Olson SD, Ylostalo J et al. Differentiation, cell fusion, and nuclear fusion during ex vivo repair of epithelium by human adult stem cells from bone marrow stroma. Proc Natl Acad Sci USA 2003;100:2397–2402.
8. Vassilopoulos G, Wang PR, Russell DW. Transplanted bone marrow regenerates liver by cell fusion. Nature 2003;422:901–904.
9. Ringdén O, Uzunel M, Rasmusson I et al. Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease. Transplantation 2006;81:1390–1397.
10. Lee RH, Pulin AA, Seo MJ et al. Intravenous hMSC improve myocardial infarction in mice because cells embolized in lung are activated to secrete the anti-inflammatory protein TSG-6. Cell Stem Cell 2009;5:54–63.
11. Parekkadan B, Milwid JM. Mesenchymal stem cells as therapeutics. Annu Rev Biomed Eng 2010;12:87–117.
12. Yáñez-Mó M, Siljander PR, Andreu Z et al. Biological properties of extracellular vesicles and their physiological functions. J Extracell Vesicles 2015;4:27066.
13. Rani S, Ryan AE, Griffin MD et al. Mesenchymal stem cell-derived extracellular vesicles: Toward cell-free therapeutic applications. Mol Ther 2015;5:812–823.
14. Yu B, Zhang X, Li X. Exosomes derived from mesenchymal stem cells. Int J Mol Sci 2014;15:4142–4157.
15. Ragni E, Lommel M, Moro M et al. Protein O-mannosylation is crucial for human mesencyhmal stem cells fate. Cell Mol Life Sci 2016;73:445–458.
16. Dominici M, Le Blanc K, Mueller I et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006;8:315–317.
17. Ragni E, Viganò M, Rebulla P et al. What is beyond a qRT-PCR study on mesenchymal stem cell differentiation properties: How to choose the most reliable housekeeping genes. J Cell Mol Med 2013;17:168–180.
18. Deng J, Kohda Y, Chiao H et al. Interleukin-10 inhibits ischemic and cisplatin-induced acute renal injury. Kidney Int 2001;60:2118–2128.
19. Mu W, Ouyang X, Agarwal A et al. IL-10 suppresses chemokines, inflammation, and fibrosis in a model of chronic renal disease. J Am Soc Nephrol 2005;16:3651–3660.
20. Deregibus MC, Cantaluppi V, Calogero R et al. Endothelial progenitor cell-derived microvesicles activate an angiogenic program in endothelial cells by a horizontal transfer of mRNA. Blood 2007;110:2440–2448.
21. Valadi H, Ekström K, Bossios A et al. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007;9:654–659.
22. Bolstad BM, Irizarry RA, Astrand M et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003;19:185–193.
23. Bruno S, Grange C, Deregibus MC et al. Mesenchymal stem cell-derived microvesicles protect against acute tubular injury. J Am Soc Nephrol 2009;20:1053–1067.
24. Zhu YG, Feng XM, Abbott J et al. Human mesenchymal stem cell microvesicles for treatment of Escherichia coli endotoxin-induced acute lung injury in mice. Stem Cells 2014;32:116–125.
25. Vandesompele JD, Preter K, Pattyn F et al. Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 2002;3:RESEARCH0034.
26. D'haene B, Mestdagh P, Hellemans J et al. miRNA expression profiling: From reference genes to global mean normalization. Methods Mol Biol 2012;822:261–272.
27. Bolukbasi MF, Mizrak A, Ozdener GB et al. miR-1289 and “zipcode”-like sequence enrich mRNAs in microvesicles. Mol Ther Nucleic Acids 2012;1:e10.
28. Batagov AO, Kuznetsov VA, Kurochkin IV. Identification of nucleotide patterns enriched in secreted RNAs as putative cis-acting elements targeting them to exosome nano-vesicles. BMC Genomics 2011;12:S18.
29. Waris S, Wilce MC, Wilce JA. RNA recognition and stress granule formation by TIA proteins. Int J Mol Sci 2014;15:23377–23388.
30. Batagov AO, Kurochkin IV. Exosomes secreted by human cells transport largely mRNA fragments that are enriched in the 3'-untranslated regions. Biol Direct 2013;8:12.
31. Dweep H, Gretz N, Felekkis K. A schematic workflow for collecting information about the interaction between copy number variants and microRNAs using existing resources. Methods Mol Biol 2014;1182:307–320.
32. Morigi M, Rota C, Montemurro T et al. Life-sparing effect of human cord blood-mesenchymal stem cells in experimental acute kidney injury. Stem Cells 2010;28:513–522.
33. Soranno DE, Rodell CB, Altmann C et al. Delivery of interleukin-10 via injectable hydrogels improves renal outcomes and reduces systemic inflammation following ischemic acute kidney injury in mice. Am J Physiol Renal Physiol 2016;311:F362–F372.
34. Liu Y, Lu Q. Extracellular vesicle microRNAs: Biomarker discovery in various diseases based on RT-qPCR. Biomark Med 2015;9:791–805.
35. Fujita Y, Yoshioka Y, Ochiya T. Extracellular vesicle transfer of cancer pathogenic components. Cancer Sci 2016;107:385–390.
36. Quesenberry PJ, Aliotta J, Deregibus MC et al. Role of extracellular RNA-carrying vesicles in cell differentiation and reprogramming. Stem Cell Res Ther 2015;6:153.
37. Nawaz M, Fatima F, Vallabhaneni KC et al. Extracellular vesicles: Evolving factors in stem cell biology. Stem Cells Int 2016;2016:1073140.
38. Lee C, Mitsialis SA, Aslam M et al. Exosomes mediate the cytoprotective action of mesenchymal stromal cells on hypoxia-induced pulmonary hypertension. Circulation 2012;126:2601.
39. Li T, Yan Y, Wang B et al. Exosomes derived from human umbilical cord mesenchymal stem cells alleviate liver fibrosis. Stem Cells Dev 2013;22:845–854.
40. Tan CY, Lai RC, Wong W. Mesenchymal stem cell-derived exosomes promote hepatic regeneration in drug-induced liver injury models. Stem Cell Res Ther 2014;5:76.
41. Kilpinen L, Impola U, Sankkila L et al. Extracellular membrane vesicles from umbilical cord blood-derived MSC protect against ischemic acute kidney injury, a feature that is lost after inflammatory conditioning. J Extracell Vesicles 2013;2:21927.
42. Zhang X, Hirai M, Cantero S et al. Isolation and characterization of mesenchymal stem cells from human umbilical cord blood: Reevaluation of critical factors for successful isolation and high ability to proliferate and differentiate to chondrocytes as compared to mesenchymal stem cells from bone marrow and adipose tissue. J Cell Biochem 2011;112:1206–1218.
43. Barilani M, Lavazza C, Viganò M et al. Dissection of the cord blood stromal component reveals predictive parameters for culture outcome. Stem Cells Dev 2015;24:104–114.
44. Shentu TP, Wong S, Espinoza C et al. Extracellular vesicles isolated from human mesenchymal stem cells promote resolution of pulmonary fibrosis. FASEB J 2016;30 no. 1 Supplement 160.2.
45. Chen TS, Lai RC, Lee MM et al. Mesenchymal stem cell secretes microparticles enriched in pre-microRNAs. Nucleic Acids Res 2010;1:215–224.
46. Iavello A, Frech VS, Gai C et al. Role of Alix in miRNA packaging during extracellular vesicle biogenesis. Int J Mol Med 2016;37:958–966.
47. Jin Y, Liu R, Xie J et al. Interleukin-10 deficiency aggravates kidney inflammation and fibrosis in the unilateral ureteral obstruction mouse model. Lab Invest 2013;93:801–811.
48. Morigi M, Benigni A. Mesenchymal stem cells and kidney repair. Nephrol Dial Transplant 2013;28:788–793.
49. Tomasoni S, Longaretti L, Rota C et al. Transfer of growth factor receptor mRNA via exosomes unravels the regenerative effect of mesenchymal stem cells. Stem Cells Dev 2013;22:772–780.
50. Bushell M, Stoneley M, Sarnow P et al. Translation inhibition during the induction of apoptosis: RNA or protein degradation?. Biochem Soc Trans 2004;32:606–610.
51. Bruno S, Grange C, Collino F et al. Microvesicles derived from mesenchymal stem cells enhance survival in a lethal model of acute kidney injury. PLoS One 2012;7:e33115.
52. Zhang B, Wang M, Gong A et al. HucMSC-exosome mediated-Wnt4 signaling is required for cutaneous wound healing. Stem Cells 2015;33:2158–2168.
53. Gatti S, Bruno S, Deregibus MC et al. Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury. Nephrol Dial Transplant 2011;26:1474–1483.
54. Carmona-Saez P, Chagoyen M, Tirado F et al. GENECODIS: A web-based tool for finding significant concurrent annotations in gene lists. Genome Biol 2007;8:R3.
55. Deans RJ, Moseley AB. Mesenchymal stem cells. Exp Hematol 2000;28:875–884.
56. Nogales-Cadenas R, Carmona-Saez P, Vazquez M et al. GeneCodis: Interpreting gene lists through enrichment analysis and integration of diverse biological information. Nucleic Acids Res 2009;37:W317–W322.
57. Tabas-Madrid D, Nogales-Cadenas R, Pascual-Montano A. GeneCodis3: A non-redundant and modular enrichment analysis tool for functional genomics. Nucleic Acids Res 2012;40:W478–W483.